Five PLus Year EffIcacy of Endoscopic Sleeve Gastroplasty (ESG) for Sustained WeigHT Loss

Stopped early

Conditions studied: Obesity and Obesity-related Medical Conditions, Weight Loss

In brief

The objective of this study is to assess the long term weight loss and weight loss journey of patients who received an Endoscopic Sleeve Gastroplasty (ESG) 5 or more years prior to enrollment.

Key facts

Study ID

NCT06894498

Run by

Boston Scientific Corporation

People needed

2

Starts

2026-03-31

Expected to finish

2026-07-30

Last updated by the study team

2026-08-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject is ≥ 18 years of age at the time of the ESG procedure
• Subject with a BMI between 30 kg/m2 and 50 kg/m2, inclusive, at the time of the primary ESG procedure using Overstitch Endoscopic Suturing System
• Subject completed follow-up 1-year from the ESG procedure for weight loss management
• Subject completed or is eligible for follow-up 5-years from the ESG procedure for weight loss management (visit can be collected either retrospectively or prospectively)
• Subject has returned for a minimum of one annual follow-up at the treating site for weight loss management annually between two and four years from the procedure.
• Subject is willing to complete one prospective visit (5 year or 5+ year, as appropriate)
• Subject is able to read, understand, and sign a written Informed Consent Form to participate in the study

You may not qualify if…

• None

Where it is running

• Endeavor Health Evanston Hospital — Evanston, Illinois, United States
• The University of Texas Health Science Center at Houston — Bellaire, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.